20/20 Biolabs
AIDX0.44133.22% ( -0.0147 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: 20/20 Biolabs(AIDX) predict that the Revenue is 353.38 K (--%), Miss estimate;the EBIT is -1.443 M (--%), Miss estimate;the EPS is -0.28 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B--
0.00B--
-0.00B--%
EBITMiss expectations
-0.00B--
-0.00B--
-0.00B--%
EPSMiss expectations
-0.28--
-0.1--
-0.1800--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf